We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Fully-Automated Chemiluminescence Analyzer Enables Fast, Convenient Testing in Clinical and Emergency Settings

By LabMedica International staff writers
Posted on 15 May 2023
Print article
Image: The MCL60 fully-automated chemiluminescence analyzer (Photo courtesy of RealMind)
Image: The MCL60 fully-automated chemiluminescence analyzer (Photo courtesy of RealMind)

In recent times, there has been a surge in the need for fast and convenient testing in clinical and emergency scenarios. Furthermore, the constant rise in the standards for test performance and result accuracy is driving advancements in in-vitro diagnostic (IVD) test platforms. Now, a strategic partnership has now further expanded the range of diagnostic solutions available for laboratories in China by offering a fully automated chemiluminescence immunoassay (CLIA) analyzer along with compatible assay kits to serve the region's patient community.

Roche Diagnostics China (Basel, Switzerland) is the exclusive agent in mainland China of RealMind Biotech’s (Nanjing, China) MCL60 CLIA analyzer, along with its matching chemiluminescence assay kits (including cardiac biomarkers, inflammatory biomarkers, sexual hormones, thyroid function, stomach function, etc.). The MCL60 bench-top CLIA system employs direct CLIA with acridinium ester (AE) label and is compatible with various sample types, such as capillary blood, whole blood, serum, and plasma. The MCL60 is fully automated with a throughput of up to 144 tests/hour, and the first result is available in 13 minutes. It fulfills the clinical requirements for flexible, convenient, precise, and efficient testing, and is applicable in a wide range of departments including pediatrics, obstetrics, emergency, and ICUs.

Traditional automatic chemiluminescence analyzers are typically larger in size, come with numerous accessories, and are costly, hence they are typically situated only in central or emergency laboratories. The MCL60 integrates the benefits of CLIA technology into a more compact platform, achieving high-accuracy, high-throughput, and miniaturized automatic CLIA testing. It requires minimal lab space and can execute over 70 highly sensitive assays including cardiac, inflammatory, children growth hormones, gastric function, cytokines, glycometabolism, preeclampsia, etc.

Related Links:
RealMind Biotech 
Roche Diagnostics China 

Platinum Supplier
Ultra-Low PSA Control
Prostate-Specific Antigen Control
Incubation & Imaging System
BD KiestraReadA
Portable Coagulation Monitor

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more


view channel
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group plc (London, UK), a life sciences company developing oncology drugs and diagnostics, has acquired Coris Bioconcept SRL (Gembloux, Belgium) for an upfront cash consideration of GBP 7.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.